GAO: Progress in FDA’s Overseas Inspections Still Hurt by Vacancies

International Pharmaceutical Regulatory Monitor
A A
The FDA has made great strides in conducting international inspections — but still remains detrimentally understaffed, according to the government’s official watchdog, during a time when the agency has begun to inspect more sites overseas than within the U.S.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00